|
Mexate-aqDrug - Mexate-aq The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Methotrexate Sodium
Strength -
EQ 25MG BASE/ML
Applicant -
BRISTOL MYERS
New Drug Application (NDA) Number -
088760
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Feb 14, 1985
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Bristol Myers Co
Mexate-aq
Methotrexate Sodium Preservative Free Eq 1gm Base/vial Injectable; Injection
Mexate Eq 100mg Base/vial Injectable; Injection Mexate Eq 20mg Base/vial Injectable; Injection Mexate Eq 250mg Base/vial Injectable; Injection Mexate Eq 50mg Base/vial Injectable; Injection Mexate-aq Eq 25mg Base/ml Injectable; Injection Methotrexate Sodium Eq 25mg Base/ml Injectable; Injection Methotrexate Sodium Eq 50mg Base/vial Injectable; Injection Methotrexate Sodium Eq 25mg Base/ml Injectable; Injection Methotrexate Sodium Eq 25mg Base/ml Injectable; Injection NewDrugInformation |